Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Eva, Tsalikian"'
Autor:
Allan L. Reiss, Booil Jo, Ana Maria Arbelaez, Eva Tsalikian, Bruce Buckingham, Stuart A. Weinzimer, Larry A. Fox, Allison Cato, Neil H. White, Michael Tansey, Tandy Aye, William Tamborlane, Kimberly Englert, John Lum, Paul Mazaika, Lara Foland-Ross, Matthew Marzelli, Nelly Mauras, the Diabetes Research in Children Network (DirecNet) Consortium
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Children with type 1 diabetes (T1D) are at risk for reduced cognitive ability and atypical brain development. This study shows that brain and cognitive measures can be improved in adolescents with T1D using a semi-automated insulin delivery system.
Externí odkaz:
https://doaj.org/article/6e1b0283be3d421a8b3de8b707955de4
Autor:
Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J. Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James G. McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team
Publikováno v:
JCI Insight, Vol 6, Iss 21 (2021)
Background IL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of residual β cell function in
Externí odkaz:
https://doaj.org/article/083a57294536479793c92cf07ad43e13
Autor:
Lori M Laffel, Thomas Danne, Georgeanna J Klingensmith, William V Tamborlane, Steven Willi, Philip Zeitler, Dietmar Neubacher, Jan Marquard, Tatiana Bardymova, Margarita Barrientos Perez, Kathleen Bethin, Petter Bjornstad, Irina Bondar, Mimi Chen, Jin-Ho Choi, Mark A Clements, Javier Ricardo Colomar, Mark Daniels, Chaicharn Deerochanawong, Vivek S Desai, Jean-Claude G Desmangles, Robert G Dillon, Naznin M Dixit, Hongwei Du, Rachel Edelen, Diego Espinoza Peralta, María Verónica Felipe Gacioppo, Tania Maria Bulcão Lousada Ferraz, Galina Galkina, Mary Patricia Gallagher, Minu George, Edgar Gonzalez, Michael Everett Gottschalk, Giancarlo Guido, Amir Ali Hassan, Eli Hershkovitz, Lina P Huerta-Saenz, Jin Soon Hwang, Jaime Orlando Ibarra Gomez, Lydia Irizarry Gonzalez, Nina Jain, David H Jelley, Ho-Seong Kim, Tatiana Kovalenko, Lori Michelle B Laffel, Steven B Leichter, Raphael Del Roio Liberatore Jr, Jane Lynch, Farid Hussain Mahmud, Oleg Arturovich Malievskiy, Andrew Muir, Bryce A Nelson, Luis Alejandro Nevarez Ruiz, Micah L Olson, Emilia Susana Pelayo Orozco, Valentina Peterkova, Fernando Ramón Ramírez Mendoza, Konda Mohan Reddy, Henry Rodriguez, Javier Andres Saenz, Julia Samoilova, Karl-Otfried Schwab, Sejal H Shah, Naim Shehadeh, Ashley H Shoemaker, Yulia Skorodok, Aleksandr Sobolev, Silvana Ernestina Solís, Shylaja Srinivasan, Eva Tsalikian, Farida Valeeva, Carl D Vance, Pedro A Velasquez-Mieyer, Rafael Margarito Violante Ortiz, Olga Votyakova, Haiyan Wei, Ruth S Weinstock, Mark D Wheeler, Brandy Alexandra Wicklow, Steven M Willi, Kupper A Wintergerst, Risa M Wolf, Jamie Ruth Wood, Chandan Yaliwal, Hernán Yupanqui Lozno
Publikováno v:
The Lancet Diabetes & Endocrinology. 11:169-181
Autor:
Sushmita Sinha, Pranav S Renavikar, Michael P Crawford, Scott M Steward-Tharp, Ashley Brate, Eva Tsalikian, Michael Tansey, Ezzatollah T Shivapour, Tracey Cho, John Kamholz, Nitin J Karandikar
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0238070 (2020)
Factors regulating self-antigen directed immune-responses in autoimmunity are poorly understood. Signal regulatory protein gamma (SIRPγ) is a human T-cell specific protein with genetic variants associated with type 1 diabetes (T1D). SIRPγ's functio
Externí odkaz:
https://doaj.org/article/1e55512d7b8a45a5a6a12f43ec8393a6
Autor:
Lara C Foland-Ross, Bruce Buckingam, Nelly Mauras, Ana Maria Arbelaez, William V Tamborlane, Eva Tsalikian, Allison Cato, Gabby Tong, Kimberly Englert, Paul K Mazaika, Allan L Reiss, Diabetes Research in Children Network (DirecNet)
Publikováno v:
PLoS Medicine, Vol 16, Iss 12, p e1002979 (2019)
BackgroundOptimal glycemic control is particularly difficult to achieve in children and adolescents with type 1 diabetes (T1D), yet the influence of dysglycemia on the developing brain remains poorly understood.Methods and findingsUsing a large multi
Externí odkaz:
https://doaj.org/article/6c3c74fd2a7a4b7daa733013570c3450
Autor:
Catherina T. Pinnaro, M. Bridget Zimmerman, Karissa Soltys, Eva Tsalikian, Andrew W. Norris, Benjamin A. Palmer, Michael Tansey
Publikováno v:
J Diabetes Sci Technol
Background: The majority of youth with type 1 diabetes (T1D) fail to meet glycemic targets despite increasing continuous glucose monitoring (CGM) use. We therefore aimed to determine the proportion of caregivers who review recent glycemic trends (“
Autor:
Hanyang Shen, Ana Maria Arbelaez, Michael Tansey, Allison Cato, Paul K. Mazaika, Lara C. Foland-Ross, Kimberly Englert, William V. Tamborlane, Allan L. Reiss, Tamara Hershey, Nelly Mauras, Matthew J. Marzelli, Stuart A. Weinzimer, Eva Tsalikian, Tandy Aye, Booil Jo, Neil H. White, Bruce A. Buckingham, Larry A. Fox
Publikováno v:
Diabetes Care
OBJECTIVE To assess whether previously observed brain and cognitive differences between children with type 1 diabetes and control subjects without diabetes persist, worsen, or improve as children grow into puberty and whether differences are associat
Autor:
William H. Lagarde, Eva Tsalikian, Kimberly Steinmann, Barry Reiner, Steven M. Willi, Kecia L. Courtney
Publikováno v:
Pediatric Diabetes
Background While circulating levels of alpha1‐proteinase inhibitor (alpha1‐PI) are typically normal, antiprotease activity appears to be compromised in patients with Type 1 diabetes mellitus (T1DM). Because alpha1‐PI [human] (alpha1‐PI[h]) th
Autor:
Antoinette Moran, S. Alice Long, Philip Raskin, James McNamara, William E. Russell, Carol L. Soppe, Sai Kanaparthi, Elisavet Serti, Hendrik J. Nel, Kevan C. Herold, Sandra Lord, Lia J Weiner, Steven M. Willi, Lynette Keyes-Elstein, Kurt J Griffin, Robin Goland, Ranjeny Thomas, Stephen E. Gitelman, Mark Harris, Henry Rodriguez, Karen Cerosaletti, Linda A. DiMeglio, Darrell M. Wilson, Itn Ai Extend Study Team, Wayne V. Moore, Srinath Sanda, Carla J. Greenbaum, Maria E. Craig, David A. Baidal, Kristina M. Utzschneider, Jason L. Gaglia, Katharina Lambert, Eva Tsalikian, Karen D. Boyle, Desmond A. Schatz, Jane H. Buckner
Publikováno v:
JCI Insight
JCI insight, vol 6, iss 21
JCI insight, vol 6, iss 21
Background IL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of residual β cell function in
Autor:
Kevan C, Herold, Brian N, Bundy, S Alice, Long, Jeffrey A, Bluestone, Linda A, DiMeglio, Matthew J, Dufort, Stephen E, Gitelman, Peter A, Gottlieb, Jeffrey P, Krischer, Peter S, Linsley, Jennifer B, Marks, Wayne, Moore, Antoinette, Moran, Henry, Rodriguez, William E, Russell, Desmond, Schatz, Jay S, Skyler, Eva, Tsalikian, Diane K, Wherrett, Anette-Gabriele, Ziegler, Carla J, Greenbaum, Stuart, Weinzimer
Publikováno v:
The New England journal of medicine, vol 381, iss 7
BackgroundType 1 diabetes is a chronic autoimmune disease that leads to destruction of insulin-producing beta cells and dependence on exogenous insulin for survival. Some interventions have delayed the loss of insulin production in patients with type